Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants

Nucleic Acids Research

Volumn 44, Issue 13, 2016, Pages 6274-6286

  Xi, Ruibin ^a   Lee, Semin ^b   Xia, Yuchao ^a   Kim, Tae Min ^c   Park, Peter J ^b  

^a PEKING UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; CARRIER PROTEIN; DNA BINDING PROTEIN; ERBB2 PROTEIN, HUMAN; GOLPH3 PROTEIN, HUMAN; MEMBRANE PROTEIN; MLL2 PROTEIN, HUMAN; NPM2 PROTEIN, HUMAN; NUCLEOPLASMIN; PLAG1 PROTEIN, HUMAN; RERE PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BAYESIAN INFORMATION CRITERION SEQ2 ALGORITHM; BLOOD; CANCER GENETICS; CANCER PATIENT; CANCER SUSCEPTIBILITY; CHROMATIN; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; ERBB2 GENE; GENE; GENE DELETION; GENE SEQUENCE; GENETIC ALGORITHM; GENOME; GOLPH3 GENE; HUMAN; KMT2C GENE; NPM2 GENE; PLAG1 GENE; PRIORITY JOURNAL; RERE GENE; WHOLE GENOME SEQUENCING; ALGORITHM; BAYES THEOREM; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLORECTAL TUMOR; DNA BASE COMPOSITION; DNA SEQUENCE; GENETICS; HUMAN GENOME; PATHOLOGY; PROCEDURES;

ALGORITHMS; BASE COMPOSITION; BAYES THEOREM; CARRIER PROTEINS; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLORECTAL NEOPLASMS; DNA COPY NUMBER VARIATIONS; DNA-BINDING PROTEINS; GENOME, HUMAN; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NUCLEOPLASMINS; RECEPTOR, ERBB-2; SEQUENCE ANALYSIS, DNA;

EID: 84982824750     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw491     Document Type: Article

References (69)

1. Diskin, S.J., Hou, C., Glessner, J.T., Attiyeh, E.F., Laudenslager, M., Bosse, K., Cole, K., Mosse, Y.P., Wood, A., Lynch, J.E. et al. (2009) Copy number variation at 1q21.1 associated with neuroblastoma. Nature, 459, 987-991.
2. Kuiper, R.P., Ligtenberg, M.J., Hoogerbrugge, N. and Geurts van, K.A. (2010) Germline copy number variation and cancer risk. Curr. Opin. Genet. Dev., 20, 282-289.
3. Yoshihara, K., Tajima, A., Adachi, S., Quan, J., Sekine, M., Kase, H., Yahata, T., Inoue, I. and Tanaka, K. (2011) Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer, 50, 167-177.
4. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O.P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J.E. et al. (2008) Large recurrent microdeletions associated with schizophrenia. Nature, 455, 232-236.
5. Fanciulli, M., Norsworthy, P.J., Petretto, E., Dong, R., Harper, L., Kamesh, L., Heward, J.M., Gough, S.C., de, S.A., Blakemore, A.I. et al. (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet., 39, 721-723.
6. Stratton, M.R., Campbell, P.J. and Futreal, P.A. (2009) The cancer genome. Nature, 458, 719-724.
7. Chen, K., Wallis, J.W., McLellan, M.D., Larson, D.E., Kalicki, J.M., Pohl, C.S., McGrath, S.D., Wendl, M.C., Zhang, Q., Locke, D.P. et al. (2009) BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat. Methods, 6, 677-681.
8. Hormozdiari, F., Alkan, C., Eichler, E.E. and Sahinalp, S.C. (2009) Combinatorial algorithms for structural variation detection in high-throughput sequenced genomes. Genome Res., 19, 1270-1278.
9. Korbel, J.O., Abyzov, A., Mu, X.J., Carriero, N., Cayting, P., Zhang, Z., Snyder, M. and Gerstein, M.B. (2009) PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing data. Genome Biol., 10, R23.
10. Abyzov, A., Urban, A.E., Snyder, M. and Gerstein, M. (2011) CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res., 21, 974-984.
11. Boeva, V., Zinovyev, A., Bleakley, K., Vert, J.P., Janoueix-Lerosey, I., Delattre, O. and Barillot, E. (2011) Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. Bioinformatics, 27, 268-269.
12. Miller, C.A., Hampton, O., Coarfa, C. and Milosavljevic, A. (2011) ReadDepth: a parallel R package for detecting copy number alterations from short sequencing reads. PLoS. One, 6, e16327.
13. Xi, R., Hadjipanayis, A.G., Luquette, L.J., Kim, T.M., Lee, E., Zhang, J., Johnson, M.D., Muzny, D.M., Wheeler, D.A., Gibbs, R.A. et al. (2011) Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proc. Natl. Acad. Sci. U.S.A., 108, E1128-E1136.
14. Chiang, D.Y., Getz, G., Jaffe, D.B., O'Kelly, M.J., Zhao, X., Carter, S.L., Russ, C., Nusbaum, C., Meyerson, M. and Lander, E.S. (2009) High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods, 6, 99-103.
15. Szatkiewicz, J.P., Wang, W., Sullivan, P.F., Wang, W. and Sun, W. (2013) Improving detection of copy-number variation by simultaneous bias correction and read-depth segmentation. Nucleic. Acids Res., 41, 1519-1532.
16. Scheinin, I., Sie, D., Bengtsson, H., van de Wiel, M.A., Olshen, A.B., van Thuijl, H.F., van Essen, H.F., Eijk, P.P., Rustenburg, F., Meijer, G.A. et al. (2014) DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome. Res., 24, 2022-2032.
17. Hansen, K.D., Brenner, S.E. and Dudoit, S. (2010) Biases in Illumina transcriptome sequencing caused by random hexamer priming. Nucleic Acids Res., 38, e131.
18. Aird, D., Ross, M.G., Chen, W.S., Danielsson, M., Fennell, T., Russ, C., Jaffe, D.B., Nusbaum, C. and Gnirke, A. (2011) Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome. Biol., 12, R18.
19. Wood, S.N. (2008) Fast stable direct fitting and smoothness selection for generalized additive models. J. R. Stat. Soc. B, 70, 495-518.
20. Li, H. and Durbin, R. (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics., 25, 1754-1760.
21. Richter, D.C., Ott, F., Auch, A.F., Schmid, R. and Huson, D.H. (2008) MetaSim: a sequencing simulator for genomics and metagenomics. PLoS One, 3, e3373.
22. Mills, R.E., Walter, K., Stewart, C., Handsaker, R.E., Chen, K., Alkan, C., Abyzov, A., Yoon, S.C., Ye, K., Cheetham, R.K. et al. (2011) Mapping copy number variation by population-scale genome sequencing. Nature, 470, 59-65.
23. Zack, T.I., Schumacher, S.E., Carter, S.L., Cherniack, A.D., Saksena, G., Tabak, B., Lawrence, M.S., Zhang, C.Z., Wala, J., Mermel, C.H. et al. (2013) Pan-cancer patterns of somatic copy number alteration. Nat. Genet., 45, 1134-1140.
24. Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J.C., Huang, J.H., Alexander, S. et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. U.S.A., 104, 20007-20012.
25. Network, Cancer Genome Atlas Research (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
26. Higgins, M.E., Claremont, M., Major, J.E., Sander, C. and Lash, A.E. (2007) CancerGenes: a gene selection resource for cancer genome projects. Nucleic. Acids Res., 35, D721-D726.
27. Handsaker, R.E., Korn, J.M., Nemesh, J. and McCarroll, S.A. (2011) Discovery and genotyping of genome structural polymorphism by sequencing on a population scale. Nat. Genet., 43, 269-276.
28. Huang, d.W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
29. Huang, D.W., Sherman, B.T. and Lempicki, R.A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic. Acids Res., 37, 1-13.
30. Bunney, T.D. and Katan, M. (2010) Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat. Rev. Cancer, 10, 342-352.
31. Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M.C., Zimmerman, L.J., Shaddox, K.F., Kim, S. et al. (2014) Proteogenomic characterization of human colon and rectal cancer. Nature, 513, 382-387.
32. Emerling, B.M., Hurov, J.B., Poulogiannis, G., Tsukazawa, K.S., Choo-Wing, R., Wulf, G.M., Bell, E.L., Shim, H.S., Lamia, K.A., Rameh, L.E. et al. (2013) Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors. Cell, 155, 844-857.
33. Luoh, S.W., Venkatesan, N. and Tripathi, R. (2004) Overexpression of the amplified Pip4k2beta gene from 17q11-12 in breast cancer cells confers proliferation advantage. Oncogene, 23, 1354-1363.
34. Jones, S., Wang, T.L., Shih, I., Mao, T.L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L.A. Jr, Vogelstein, B. et al. (2010) Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science, 330, 228-231.
35. Wang, K., Yuen, S.T., Xu, J., Lee, S.P., Yan, H.H., Shi, S.T., Siu, H.C., Deng, S., Chu, K.M., Law, S. et al. (2014) Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet., 46, 573-582.
36. Wu, R.C., Wang, T.L. and Shih, I. (2014) The emerging roles of ARID1A in tumor suppression. Cancer Biol. Ther., 15, 655-664.
37. Waerner, T., Gardellin, P., Pfizenmaier, K., Weith, A. and Kraut, N. (2001) Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis. Cell Growth. Differ., 12, 201-210.
38. Koga, Y., Pelizzola, M., Cheng, E., Krauthammer, M., Sznol, M., Ariyan, S., Narayan, D., Molinaro, A.M., Halaban, R. and Weissman, S.M. (2009) Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome. Res., 19, 1462-1470.
39. Kroeger, H., Jelinek, J., Estecio, M.R., He, R., Kondo, K., Chung, W., Zhang, L., Shen, L., Kantarjian, H.M., Bueso-Ramos, C.E. et al. (2008) Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood, 112, 1366-1373.
40. Pinto, D., Darvishi, K., Shi, X., Rajan, D., Rigler, D., Fitzgerald, T., Lionel, A.C., Thiruvahindrapuram, B., Macdonald, J.R., Mills, R. et al. (2011) Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat. Biotechnol., 29, 512-520.
41. Conrad, D.F., Pinto, D., Redon, R., Feuk, L., Gokcumen, O., Zhang, Y., Aerts, J., Andrews, T.D., Barnes, C., Campbell, P. et al. (2010) Origins and functional impact of copy number variation in the human genome. Nature, 464, 704-712.
42. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
43. Silva, A.G., Krepischi, A.C., Torrezan, G.T., Capelli, L.P., Carraro, D.M., D'Angelo, C.S., Koiffmann, C.P., Zatz, M., Naslavsky, M.S., Masotti, C. et al. (2014) Does germ-line deletion of the PIP gene constitute a widespread risk for cancer? Eur. J. Hum. Genet., 22, 307-309.
44. Luo, M.H., Huang, Y.H., Ni, Y.B., Tsang, J.Y., Chan, S.K., Shao, M.M. and Tse, G.M. (2013) Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. Hum. Pathol., 44, 1241-1250.
45. Shlien, A., Tabori, U., Marshall, C.R., Pienkowska, M., Feuk, L., Novokmet, A., Nanda, S., Druker, H., Scherer, S.W. and Malkin, D. (2008) Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc. Natl. Acad. Sci. U.S.A., 105, 11264-11269.
46. Prasad, R., Gu, Y., Alder, H., Nakamura, T., Canaani, O., Saito, H., Huebner, K., Gale, R.P., Nowell, P.C., Kuriyama, K. et al. (1993) Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res., 53, 5624-5628.
47. Zang, Z.J., Cutcutache, I., Poon, S.L., Zhang, S.L., McPherson, J.R., Tao, J., Rajasegaran, V., Heng, H.L., Deng, N., Gan, A. et al. (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet., 44, 570-574.
48. Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K.A., Hosoda, F., Nguyen, H.H., Aoki, M., Hosono, N., Kubo, M., Miya, F. et al. (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet., 44, 760-764.
49. Ong, C.K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J.R., Allen, G.E., Ng, C.C., Wong, B.H. et al. (2012) Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat. Genet., 44, 690-693.
50. Kanchi, K.L., Johnson, K.J., Lu, C., McLellan, M.D., Leiserson, M.D., Wendl, M.C., Zhang, Q., Koboldt, D.C., Xie, M., Kandoth, C. et al. (2014) Integrated analysis of germline and somatic variants in ovarian cancer. Nat. Commun., 5, 3156.
51. Li, W.D., Li, Q.R., Xu, S.N., Wei, F.J., Ye, Z.J., Cheng, J.K. and Chen, J.P. (2013) Exome sequencing identifies an MLL3 gene germ line mutation in a pedigree of colorectal cancer and acute myeloid leukemia. Blood, 121, 1478-1479.
52. Scott, K.L., Kabbarah, O., Liang, M.C., Ivanova, E., Anagnostou, V., Wu, J., Dhakal, S., Wu, M., Chen, S., Feinberg, T. et al. (2009) GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature, 459, 1085-1090.
53. Buschman, M.D., Rahajeng, J. and Field, S.J. (2015) GOLPH3 links the Golgi, DNA damage, and cancer. Cancer Res., 75, 624-627.
54. Zeng, Z., Lin, H., Zhao, X., Liu, G., Wang, X., Xu, R., Chen, K., Li, J. and Song, L. (2012) Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin. Cancer Res., 18, 4059-4069.
55. Zhang, Y., Ma, M. and Han, B. (2014) GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis. Tumour Biol., 35, 10833-10839.
56. Chaib, H., Rubin, M.A., Mucci, N.R., Li, L., Taylor, J.M.G., Day, M.L., Rhim, J.S. and Macoska, J.A. (2001) Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors. Cancer Res., 61, 2390-2394.
57. Nagirnaja, L., Palta, P., Kasak, L., Rull, K., Christiansen, O.B., Nielsen, H.S., Steffensen, R., Esko, T., Remm, M. and Laan, M. (2014) Structural genomic variation as risk factor for idiopathic recurrent miscarriage. Hum. Mutat., 35, 972-982.
58. Tanwar, P.S., Kaneko-Tarui, T., Zhang, L. and Teixeira, J.M. (2012) Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis. Hum. Mol. Genet., 21, 4394-4405.
59. Wen, H.Y., Abbasi, S., Kellems, R.E. and Xia, Y. (2005) mTOR: a placental growth signaling sensor. Placenta, 26(Suppl A), S63-S69.
60. Jilaveanu, L.B., Parisi, F., Barr, M.L., Zito, C.R., Cruz-Munoz, W., Kerbel, R.S., Rimm, D.L., Bosenberg, M.W., Halaban, R., Kluger, Y. et al. (2015) PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis. Clin. Cancer Res., 21, 2138-2147.
61. Declercq, J., Van, D.F., Braem, C.V., Van Valckenborgh, I.C., Voz, M., Wassef, M., Schoonjans, L., Van, D.B., Fiette, L. and Van de Ven, W.J. (2005) Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression. Cancer Res., 65, 4544-4553.
62. Janjigian, Y.Y., Werner, D., Pauligk, C., Steinmetz, K., Kelsen, D.P., Jager, E., Altmannsberger, H.M., Robinson, E., Tafe, L.J., Tang, L.H. et al. (2012) Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. Ann. Oncol., 23, 2656-2662.
63. Yamamoto, H., Higasa, K., Sakaguchi, M., Shien, K., Soh, J., Ichimura, K., Furukawa, M., Hashida, S., Tsukuda, K., Takigawa, N. et al. (2014) Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas. J. Natl. Cancer Inst., 106, djt338.
64. Nik-Zainal, S., Wedge, D.C., Alexandrov, L.B., Petljak, M., Butler, A.P., Bolli, N., Davies, H.R., Knappskog, S., Martin, S., Papaemmanuil, E. et al. (2014) Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat. Genet., 46, 487-491.
65. Futreal, P.A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183.
66. Greco, A., Mariani, C., Miranda, C., Lupas, A., Pagliardini, S., Pomati, M. and Pierotti, M.A. (1995) The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol. Cell Biol., 15, 6118-6127.
67. Hernandez, L., Pinyol, M., Hernandez, S., Bea, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D.Y. et al. (1999) TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood, 94, 3265-3268.
68. Hisaoka, M., Ishida, T., Imamura, T. and Hashimoto, H. (2004) TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma. Genes. Chromosomes Cancer, 40, 325-328.
69. Chase, A., Ernst, T., Fiebig, A., Collins, A., Grand, F., Erben, P., Reiter, A., Schreiber, S. and Cross, N.C. (2010) TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals. Haematologica, 95, 20-26.